Gouty Arthritis
📧 Sign up to get email alerts when something new happens for Gouty Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of AR882 with a xanthine oxidase inhibitor co-administration in gout patients who …
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Qingzhu Granules in the Treatment of Acute Gouty Arthritis [Phase 3]
This document reports the completion of a Phase 3 clinical trial evaluating the efficacy and safety of Qingzhu Granules for acute gouty arth…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301) [Phase 3]
This entry notes a Phase 3 clinical trial (AR882-301) evaluating the efficacy and safety of AR882 in gout patients. The trial is currently a…
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: A Bioequivalence Study of Two Different Dosage Form of Genakumab [Phase 1]
This document reports the completion of a Phase 1 bioequivalence study comparing two dosage forms of Genakumab for gouty arthritis.
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: Phase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination With Allopurinol in Patients With Tophaceous Gout [Phase 2]
A Phase 2 clinical trial update evaluating AR882 alone or in combination with allopurinol for tophaceous gout has completed, focusing on eff…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: Immediate Analgesic Effects of Cheek Acupuncture for Acute Gouty Arthritis [NA]
This clinical trial reports on the immediate analgesic effects of cheek acupuncture for acute gouty arthritis. The study status is completed…
-
CLINICAL_TRIALS trial_result · 2021-07-19Clinical Trial Update: Long-Term Safety and Tolerability of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients [Phase 3]
Phase 3 trial update on long-term safety and tolerability of canakinumab prefilled syringes in patients with frequently flaring acute gouty …
-
CLINICAL_TRIALS trial_result · 2021-07-09Clinical Trial Update: β-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3) [Phase 3]
Phase 3 extension study update for a gout flare treatment (β-RELIEVED) completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-06-09Clinical Trial Update: Long Term Study of Canakinumab (ACZ885) in Patients With Gout [Phase 2]
Phase 2 long-term study of canakinumab in gouty arthritis has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-07-15Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Acute Gouty Arthritis [Phase 2]
Phase 2 trial evaluating efficacy and safety of anakinra for acute gouty arthritis has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-07-08Clinical Trial Update: Oral Huzhang Granules for Acute Gouty Arthritis [Phase 2]
A Phase 2 clinical trial update for oral Huzhang Granules in treating acute gouty arthritis.
-
CLINICAL_TRIALS trial_result · 2014-03-12Clinical Trial Update: AMPED Outcomes Registry of Post-ED Pain Management
The AMPED Outcomes Registry of Post-ED Pain Management has completed data collection to track outcomes in emergency department patients with…
-
CLINICAL_TRIALS trial_result · 2011-02-24Clinical Trial Update: Celebrex In Acute Gouty Arthritis Study [Phase 3]
Phase 3 clinical trial update for celecoxib (Celebrex) in acute gouty arthritis completed with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2006-11-30Clinical Trial Update: Efficacy and Safety of Lumiracoxib 400 mg Once Daily in Acute Flares of Gout [Phase 4]
This Phase 4 clinical trial assesses the efficacy and safety of Lumiracoxib 400 mg once daily for acute gout flares; the study has completed…